farnaz shokraneh | personalized medicine | Best Researcher Award

Posted on by ScienceFather

Ms. farnaz shokraneh | personalized medicine | Best Researcher Award

Abo Akademi University, Finland

👨‍🎓Professional Profile 

Orcid Profile

👩‍🔬 Summary

Ms. Farnaz Shokraneh is an experienced pharmaceutical professional currently working as a Doctoral Researcher in Pharmaceutical Development and Medical Technology at Ă…bo Akademi University in Turku, Finland. With a solid academic background and extensive practical experience in pharmaceutical quality assurance, regulatory compliance, and research, she brings valuable insights into the development of pharmaceutical products and systems. She is committed to advancing personalized medicine and improving quality control in the pharmaceutical industry.

🎓 Education

Ms. Shokraneh holds a Doctor of Pharmacy degree, equivalent to a Finnish Master’s, from Islamic Azad University, Tehran, Iran (2007-2012). She furthered her academic journey with a Master’s in Pharmaceutical Research from Freie Universität Berlin, Germany (2022-2024). Currently, she is pursuing her doctoral research in Pharmaceutical Development and Medical Technology at Åbo Akademi University, Turku, Finland (2022–present).

đź’Ľ Professional Experience

Ms. Shokraneh has accumulated extensive experience in various roles within the pharmaceutical industry. She is currently serving as a Quality Manager at CurifyLabs Oy in Helsinki, Finland, since September 2022. Previously, she held the position of Quality Assurance Manager at Mofid Pharma under the license of Bayer Pharmaceutical Company (Dec 2020–Dec 2021). Additionally, she has worked at Modava Pharmaceutical under Novartis (Jul 2018–Jul 2020) and ATI Pharmed Pharmaceutical Co under StragenPharma and CHEMO Pharmaceutical licenses (Apr 2013–Jun 2017).

🛠️ Technical Skills

Ms. Shokraneh’s technical expertise encompasses pharmaceutical development, quality assurance, and regulatory compliance. She is proficient in analytical techniques such as HPLC, mass spectrometry, and micro NIR spectrophotometry. Her experience also extends to pharmacovigilance, safety monitoring, and statistical analysis for pharmaceutical applications, making her highly skilled in ensuring the safety, efficacy, and quality of pharmaceutical products.

🧑‍🏫 Teaching Experience

Although Ms. Shokraneh’s current focus is on research and industry roles, her vast knowledge and experience in the pharmaceutical field allow her to effectively mentor teams and share her expertise. She has contributed to the professional development of her colleagues and participated in educational training programs within the pharmaceutical sector.

🔬 Research Interests

Ms. Shokraneh’s primary research interests lie in pharmaceutical development and medical technology, with a particular focus on personalized medicine. She is passionate about improving drug safety and efficacy through innovations in automated pharmacy compounding, quality control, and exploring new methods for drug delivery and patient-specific treatment plans.

 

đź“–Top Noted Publications

Automated Non-Sterile Pharmacy Compounding: A Multi-Site Study in European Hospital and Community Pharmacies with Pediatric Immediate Release Propranolol Hydrochloride Tablets

Authors: Niklas Sandler Topelius, Farnaz Shokraneh, Mahsa Bahman, Julius Lahtinen, Niko Hassinen, Sari Airaksinen, Soumya Verma, Ludmila Hrizanovska, Jana Lass, Urve Paaver et al.

Journal: Pharmaceutics

Year: 2024

A Novel High Performance Liquid Chromatographic Method for Determination of Nystatin in Pharmaceutical Formulations by Box–Behnken Statistical Experiment Design

Authors: Farnaz Shokraneh

Journal: Iranian Journal of Pharmaceutical Research

Year: 2014

Comparative Studies of Cytotoxic Manufacturing Practices in Specialized Cancer Centers Against International Guidelines (ASHP, OSHA, HSE-UK)

Authors: Farnaz Shokraneh

Journal: FIP Congress

Year: 2012

Development and Validation of High-Performance Liquid Chromatography for Determination of Nystatin in Pharmaceutical Formulations

Authors: Farnaz Shokraneh

Journal: Research in Pharmaceutical Science

Year: 2012

A New HPLC Method for Determination of Losartan in Human Plasma and Its Application in Bioequivalence Studies

Authors: Farnaz Shokraneh

Journal: Oriental Journal of Chemistry

Year: 2012

Risks to Health Professionals from Hazardous Drugs in Iran: A Pilot Study of Understanding of Healthcare Team to Occupational Exposure to Cytotoxics

Authors: Farnaz Shokraneh

Journal: EXCLI Journal

Year: 2005

Venkatesh Babu Gopal – Molecular Biology and Fungal Genetics- Best Researcher Award 

Posted on by ScienceFather

Dr Venkatesh Babu Gopal - Molecular Biology and Fungal Genetics- Best Researcher Award 

 University of Agricultural Sciences - india

Author Profile

Early Academic Pursuits

Dr. G. Venkatesh Babu's academic journey began with a Master's degree in Biotechnology from Loyola College, Chennai. He later pursued a Doctor of Philosophy (Ph.D.) in Biotechnology-Botany, specializing in Molecular Plant Pathology, at the Centre for Advanced Studies in Botany, University of Madras, Chennai, India. His research focused on the molecular underpinning of fungal DHN (dihydroxynaphthalene) melanin, specifically in the pathogen Curvularia lunata.

Professional Endeavors

After completing his Ph.D., Dr. Venkatesh Babu has been actively involved in the field of Molecular Phytopathology and Genetic Engineering. He is currently a Senior Researcher at the PathoGenOmics Lab in the Department of Plant Pathology at the University of Agricultural Sciences, GKVK, Bangalore, India. He is working on a project funded by United Phosphorus Pvt. Ltd. (UPL).

Contributions and Research Focus

His doctoral research focused on unraveling the molecular aspects of fungal melanin biosynthesis, with a specific emphasis on the DHN-melanin biosynthetic pathway in Curvularia lunata. This research aimed to understand the role of melanin in fungal penetration into host plants, particularly in causing the black kernel disease in rice (Oryza sativa).

Accolades and Recognition

Dr. Venkatesh Babu has received several honors, awards, and fellowships throughout his academic and research career. Notably, he was awarded the Meritorious Basic Scientific Research fellowship (BSR) from the University Grants Commission (UGC), Government of India. He also served as a Project Research Fellow for a project funded by the Department of Science and Technology (DST), Government of India.

Impact and Influence

His research has contributed significantly to the understanding of the genetic analysis of the melanin biosynthetic gene Cl3HNR in Curvularia lunata. The study explored the potential of using the Cl3HNR gene as a target for fungicides, particularly the Melanin Biosynthetic Inhibitor tricyclazole. The findings have implications for the development of commercial formulations for the management of phytopathogens in agriculture.

Legacy and Future Contributions

Dr. Venkatesh Babu's expertise lies in Molecular Phytopathology, Mycology, Fungal genomics and proteomics, Microbial Pathogenesis, Plant–microbe interaction, Molecular Biology, Genetic Engineering, and Protein Biochemistry. His dedication to collaborating with scientists from different disciplines reflects his commitment to developing innovative solutions to new challenges in these fields.

In the future, he is likely to continue making significant contributions to the field of plant pathology and genetic engineering, with a focus on practical applications for crop protection and agricultural sustainability. His current role as a Senior Researcher at UPL suggests a continued engagement in impactful research and development in the agricultural sector.

Notable Publication